US Stocks Surge on Promising Vaccine News, but Give Back Most Gains On Election ‘Irregularities’ Concerns

The benchmark S&P 500 Index and the blue chip Dow Jones Industrial Average surged early in the session but finished off their record highs on Monday as investors speculated that a full economic reopening was finally in sight after a well-known pharmaceutical firm announced the first positive results from a late-stage COVID-19 vaccine trial.

In the cash market on Monday, the S&P 500 Index settled at 3550.50, up 41.06 or +1.22%. The Dow Jones Industrial Average closed at 29157.97, up 834.57 or +3.04% and the technology-driven NASDAQ Composite finished at 11713.78, down 181.45 or -1.63%.

The markets were also supported on the opening as investors were reassured by Saturday’s news that Joe Biden had garnered enough votes to win the U.S. presidential election. However, late in the session, the markets gave back most of their earlier gains after U.S. Senate Majority Leader Mitch McConnell on Monday said President Donald Trump was completely within his rights to look into “irregularities” from last week’s election.

Impressive Vaccine Results

Pfizer and its German partner BioNTech said a large-scale trial of their vaccine showed it was more than 90% effective in preventing COVID-19. While their vaccine study is still ongoing and requires approval, Pfizer and BioNTech said they had found no serious safety concerns so far and expected to seek U.S. emergency use authorization later this month.

The news doesn’t mean the U.S. is out of the woods with the coronavirus, but if Pfizer gets approval to begin administering the vaccine, it would remove the worst case scenario – meaning the country would avoid a national lockdown. Additionally, the market is forward looking so investors are pricing in better times in the first and second quarter of next year.

Stocks Whacked by Lockdowns Post Solid Gains

With investors already looking forward to improved earnings results next year, sectors such as energy, travel and financials which were among the hardest hit by lockdowns aimed at curbing the virus were some of the biggest percentage gainers on Monday.

Tech Giants Tumble

While cyclical stocks led the market advance on Monday, the tech-heavy NASDAQ dropped as investors dumped some of the popular stay-at-home plays such as Zoom Video and Netflix. The index finished Monday’s session near its session low.

Stocks in the News

The vaccine news sent travel stocks soaring as the recovery of these companies depends on a successful economic reopening. American Airlines, Delta and United all jumped more than 15%, while Carnival, Norwegian and Royal Caribbean surged more than 25% each.

U.S. banks including Citigroup Inc and Bank of America Corp, often seen as a proxy for the broader economy, jumped about 9% each, while oil majors Exxon Mobil Corp and Chevron Corp climbed about 10%.

Losers included Netflix Inc, Inc and gaming company Activision Blizzard Inc fell between 1.5% and 4.7%.

Among other movers, McDonald’s Corp gained about 1.0% after it beat third-quarter revenue and profit estimates, as U.S. customers ordered more hamburgers and fries in drive-through outlets and on delivery apps.

The Internals

On U.S. exchanges, 17.2 million shares changed hands in the market’s busiest trading session since June and compared with the 9.68 billion average for the last 20 sessions.

Advancing issues outnumbered declining ones on the NYSE by a 3.22-to-1 ratio; on NASDAQ, a 1.96-to-1 ratio favored advancers.

The S&P 500 posted 140 new 52-week highs and 1 new low; the NASDAQ Composite recorded 246 new highs and 25 new lows, according to Reuters.

For a look at all of today’s economic events, check out our economic calendar.

Source link

0 0 voter
Article Rating

Notifier de
0 Commentaires
Commentaires en ligne
Afficher tous les commentaires
Reset Password

Avertissement sur les risques :

Le trading peut vous exposer à des risques de pertes supérieures aux dépôts et ne convient qu’à une clientèle avisée ayant les moyens financiers de supporter un tel risque. Les CFD sont des instruments complexes et présentent un risque élevé de perte rapide en capital en raison de l’effet de levier. Entre 74 et 89% des comptes de clients de détail perdent de l’argent lors de la négociation de CFD. Vous devez vous assurer que vous comprenez comment les CFD fonctionnent et que vous pouvez vous permettre de prendre le risque élevé de perdre votre argent. Ce site n’est en aucun cas une offre de conseil en investissement ni une incitation quelconque à acheter ou vendre des instruments financiers. Trader le Forex et/ou les CFD’s implique un niveau de risque élevé, et peut ne pas être approprié car vous pouvez subir des pertes supérieures à votre dépôt. L’effet de levier peut être en votre défaveur.

Vous devez être conscient et avoir une compréhension complète de tous les risques associés au marché et au trading. Le site peut être amené à produire des commentaires d’ordre général, ce qui ne constitue pas des conseils en investissement et ne doit pas être interprété comme tel.

Veuillez recourir aux conseils d’un conseiller financier extérieur. Le site décline toute responsabilité pour les erreurs, inexactitudes ou omissions et ne garantit pas l’exactitude ou le caractère complet des informations, textes, graphiques, liens ou autres éléments contenus dans cette documentation. Toute information et toute mise à disposition sur le site ont un caractère privé.